APA-referens

O’Brien, S., Furman, R. R., Coutre, S., Flinn, I. W., Burger, J. A., Blum, K., . . . Byrd, J. C. (2018). Single-agent ibrutinib in treatment-naïve and relapsed/refractory chronic lymphocytic leukemia: A 5-year experience. Blood.

Chicago-stil citat

O’Brien, Susan, et al. "Single-agent Ibrutinib in Treatment-naïve and Relapsed/refractory Chronic Lymphocytic Leukemia: A 5-year Experience." Blood 2018.

MLA-referens

O’Brien, Susan, et al. "Single-agent Ibrutinib in Treatment-naïve and Relapsed/refractory Chronic Lymphocytic Leukemia: A 5-year Experience." Blood 2018.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.